Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Exploring and comparing the curative potential of CAR-T therapy & bispecific antibodies in R/R DLBCL

    Exploring and comparing the curative potential of CAR-T therapy & bispecific antibodies in R/R DLBCL

    FromVJHemOnc Podcast

    Start listeningView podcast show

    Exploring and comparing the curative potential of CAR-T therapy & bispecific antibodies in R/R DLBCL

    FromVJHemOnc Podcast

    ratings:
    Length:
    9 minutes
    Released:
    Aug 23, 2023
    Format:
    Podcast episode

    Description

    The treatment and management of relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) remains a major unmet need, and in recent...
    The post Exploring and comparing the curative potential of CAR-T therapy & bispecific antibodies in R/R DLBCL appeared first on VJHemOnc.
    Released:
    Aug 23, 2023
    Format:
    Podcast episode

    Titles in the series (100)

    The Video Journal of Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjhemonc.com